Trade Summary

4 days ago, Stout Jay S, serving as Chief Technology Officer at Immunovant, Inc. (IMVT), sold 3,487 shares at $39.55 per share, for a total transaction value of $137,924.83. Following this transaction, Stout Jay S now holds 208,198 shares of IMVT.

This sale represents a 1.65% decrease in Stout Jay S's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Wednesday, July 8, 2026 and publicly disclosed via SEC Form 4 filing on Friday, July 10, 2026 at 4:12 PM ET, 2 days after the trade was made.

Immunovant, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.